In 2022, IFPA and IPC announced a new partnership to join their clinical expertise and the patient perspective. Here’s what they hope to achieve together.
The IPC global network has expanded! Please join us in welcoming our seven newest councilors.
IPC and IFPA strongly advocate that early diagnosis is crucial and must be available for all individuals regardless of race, ethnicity, physical ability, culture, nationality, or geographic location.
The IPC Board of Directors is pleased to announce that it has named Bruce Strober, MD, PhD, as its newly appointed Vice President/President-Elect.
Craig Leonardi, MD, a Founder of the IPC, our immediate-past President, and a long-time Board Member, has accepted the position as an Honorary Founder.
The IPC Board of Directors is pleased to announce that it has named Hervé Bachelez, MD, PhD, as its newly appointed President, effective January 1, 2023.
The IPC’s global network of experts generously volunteers their time every year to educate and train other physicians to better care for people with psoriasis. We would like to recognize our top three Councilors that went above and beyond in 2022 to support our work.
In 2022, the IPC advanced in the worldwide psoriasis community, ranging from multiple research efforts, education of dermatologists, and public awareness, reaching the patient communities. In addition to face-to-face events, the IPC has expanded its digital presence. Read some of IPC’s significant achievements from the past year and leave a comment letting us know what topics you want to see on the IPC website in the coming year!
This revised statement is based on expert opinion and should be interpreted in the context of local policies and emerging evidence.
The International Psoriasis Council (IPC) and Scientific Education Support (SES) are excited to announce a strategic collaboration aimed to improve awareness, knowledge, and understanding of psoriasis, psoriatic arthritis, and other related diseases.
IPC is pleased to introduce and welcome our five newest Councilors for 2022: Pravit Asawanonda, Sunil Dogra, Benjamin Ehst, Filip Rob, and Tsen-Fang Tsai. These individuals were confirmed by the IPC Board of Directors during the European Academy of Dermatology and Venereology (EADV) Congress in September.
Dr. Claus Johansen joins the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.
